© 2022 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
October 11, 2021
An oncologist ruminates on emerging treatment options in follicular lymphoma and offers some clinical pearls.
Alan Skarbnik, MD, explains early relapse in follicular lymphoma and the available treatment options.
An expert describes typical monitoring strategies in follicular lymphoma.
Dr. Alan Skarbnik reviews the use of obinutuzumab-based therapies for follicular lymphoma and highlights data from a phase III study.
A key opinion leader discusses the considerations in choosing induction and maintenance therapy options for follicular lymphoma.
Alan Skarbnik, MD, presents the case of a 60-year-old man with newly diagnosed follicular lymphoma.